Utility of early insulin response and proinsulin to assess insulin resistance

Amy M Jean1, Abeer Hassoun, Jennifer Hughes

  • 1Department of Pediatrics, Division of Pediatric Endocrinology, Columbia University, New York, NY 10032, USA.

Insights

Obese children with premature adrenarche exhibit higher early insulin response (EIR) and proinsulin (PI) levels, indicating an increased risk for prediabetes and type 2 diabetes. This highlights the additive impact of obesity and premature adrenarche on metabolic health.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Health
  • Diabetes Research

Background:

  • Premature adrenarche and obesity are independently associated with metabolic dysfunction.
  • Understanding their combined effects is crucial for early risk assessment in children.

Purpose of the Study:

  • To investigate if obesity and premature adrenarche act additively to increase the risk of insulin resistance and beta-cell dysfunction.
  • To utilize early insulin response (EIR) and proinsulin (PI) as key markers.

Main Methods:

  • Prospective case-control study of 81 prepubertal children.
  • Categorization into lean controls, obese controls, lean premature adrenarche, and obese premature adrenarche groups.
  • Assessment of fasting glucose, insulin, proinsulin, and oral glucose tolerance tests to calculate EIR.

Main Results:

  • Obese children, with or without premature adrenarche, showed significantly higher EIR.
  • The obese premature adrenarche group exhibited the highest EIR and elevated fasting PI levels compared to lean counterparts.
  • No significant difference was found in the fasting PI/I ratio across groups.

Conclusions:

  • Obese children with premature adrenarche demonstrate a heightened risk for developing prediabetes and type 2 diabetes mellitus.
  • EIR and PI serve as valuable indicators for assessing metabolic risk in this pediatric population.
  • Early identification and intervention are critical for mitigating long-term metabolic complications.
Abstract

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...